Paper · 6973760
Expression of cell surface markers after human B lymphocyte activation.
Stashenko P and 3 others. Proc Natl Acad Sci U S A, 1981. Cited by 244 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Expression of cell surface markers after human B lymphocyte activation. Papers, record 6973760. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6973760
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody-Producing Cells | Major topic |
| Antigens, Surface | Major topic |
| B-Lymphocytes | Major topic |
| Cell Differentiation | |
| Cytoplasm | |
| Humans | |
| Immunoglobulins | |
| Lymphocyte Activation | |
| Lymphoid Tissue | |
| Phenotype | |
| Pokeweed Mitogens | |
| Tissue Distribution |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI 12069 | NIAID NIH HHS | United States | R01AI012069 | PubMed and NIH | NIH RePORTER |
| CA 19589 | NCI NIH HHS | United States | P01CA019589 | PubMed and NIH | NIH RePORTER |
| DE-04881 | NIDCR NIH HHS | United States | P50DE004881 | PubMed and NIH | NIH RePORTER |
| R37AI012069 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,092,758 | Development of B lymphocytes. I. Cell populations and a critical event during ontogeny. | J Immunol | 1975 | https://conductscience.org/library/papers/1092758 | PubMed |
| 2 | 6,944,297 | Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. | Hum Immunol | 1981 | https://conductscience.org/library/papers/6944297 | PubMed |
| 3 | 1,097,506 | The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells. | J Immunol | 1975 | https://conductscience.org/library/papers/1097506 | PubMed |
| 4 | 810,058 | Membrane-associated immunoglobulin determinants on bone marrow and blood lymphocytes in the pediatric age group and on fetal tissues. | Ann N Y Acad Sci | 1975 | https://conductscience.org/library/papers/810058 | PubMed |
| 5 | 1,062,806 | Ontogeny of lymphocyte subpopulations in human fetal liver. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1062806 | PubMed |
| 6 | 1,083,069 | Immunoglobulin-receptors revisited. | Science | 1975 | https://conductscience.org/library/papers/1083069 | PubMed |
| 7 | 1,083,418 | The class of surface immunoglobulin on cells carrying IgG memory in rat thoracic duct lymph: the size of the subpopulation mediating IgG memory. | J Exp Med | 1976 | https://conductscience.org/library/papers/1083418 | PubMed |
| 8 | 1,083,879 | B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies. | J Immunol | 1976 | https://conductscience.org/library/papers/1083879 | PubMed |
| 9 | 1,084,527 | Ontogeny of murine B lymphocytes: sequence of B-cell differentiation from surface-immunoglobulin-negative precursors to plasma cells. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1084527 | PubMed |
| 10 | 824,081 | Assessment of a B-cell function in chronic lymphocytic leukemia. | Clin Immunol Immunopathol | 1976 | https://conductscience.org/library/papers/824081 | PubMed |
1 to 10 of 34
See all 34 referencesCited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,820,782 | Impact of Anti-CD20 Therapies on Cytokine, Chemokine and Adhesion Molecule Dynamics in Multiple Sclerosis: A Narrative Review. | Neurol Ther | 2026 | https://conductscience.org/library/papers/41820782 | PubMed |
| 41,269,450 | Exploring the Role of B-Cell Biotherapy in Myasthenia Gravis from a Genetic Perspective: A Mendelian Randomization Study. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41269450 | PubMed |
| 37,081,097 | Regulation of early diagnosis and prognostic markers of lung adenocarcinoma in immunity and hypoxia. | Sci Rep | 2023 | https://conductscience.org/library/papers/37081097 | PubMed |
| 33,880,738 | A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20-Yet Progress Continues. | Neurotherapeutics | 2021 | https://conductscience.org/library/papers/33880738 | PubMed |
| 33,352,466 | MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironment. | Cell Immunol | 2021 | https://conductscience.org/library/papers/33352466 | PubMed |
| 33,081,391 | Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33081391 | PubMed |
| 31,494,742 | Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients. | Cancer Immunol Immunother | 2019 | https://conductscience.org/library/papers/31494742 | PubMed |
| 30,967,621 | B cell checkpoints in autoimmune rheumatic diseases. | Nat Rev Rheumatol | 2019 | https://conductscience.org/library/papers/30967621 | PubMed |
| 30,050,376 | Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies. | Degener Neurol Neuromuscul Dis | 2017 | https://conductscience.org/library/papers/30050376 | PubMed |
| 29,593,838 | B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets. | Ther Adv Neurol Disord | 2018 | https://conductscience.org/library/papers/29593838 | PubMed |
1 to 10 of 60
See all 60 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GRPR | 2,925 | PubTator's text mining | https://conductscience.org/library/genes/2925 | NCBI Gene |
| MS4A1 | 931 | PubTator's text mining | https://conductscience.org/library/genes/931 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6973760
GET https://conductscience.org/api/papers/v1/6973760/references?page=2